Progression rate of total, and upper and lower visual field defects in open-angle glaucoma patients

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 1315-1323

  Fukuchi, Takeo ^a   Yoshino, Takaiko ^a   Sawada, Hideko ^a   Seki, Masaaki ^a   Togano, Tetsuya ^a   Tanaka, Takayuki ^a   Ueda, Jun ^a   Abe, Haruki ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Normal tension glaucoma; Open angle glaucoma; Primary open angle glaucoma; Progression rate; Visual field defects

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; JAPANESE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PERIMETRY; PROGNOSIS; RETROSPECTIVE STUDY; VISUAL FIELD DEFECT;

EID: 78650683349     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S13101     Document Type: Article

References (45)

1. Thylefors B, Negrel AD. The global impact of glaucoma. Bull World Health Organ. 1994;72(3):323-326.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267.
3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
4. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720.
5. Leske MC, Heijl A, Hyman L, et al. Early manifest glaucoma trial: design and baseline data. Ophthalmology. 1999;106(11):2144-2153.
6. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48-56.
7. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
8. Collaborative normal-tension glaucoma study group. Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487-497.
9. Collaborative normal-tension glaucoma study group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108(2): 247-253.
10. Anderson DR, Drance SM, Schulzer M. The Collaborative Normaltension Glaucoma Study Group: Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol. 2003;136(5):820-829.
11. The Advanced Glaucoma Intervention Study Investigators. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology. 1994;101(8):1445-1455.
12. The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS):7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-440.
13. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111(9):1627-1635.
14. Chauhan BC, Mikelberg FS, Balaszi G, et al. Canadian Glaucoma Study, 2. Risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126(10):1030-1036.
15. Goldberg I. Relationship between intraocular pressure and preservation of visual field in glaucoma. Surv Ophthalmol. 2003;48:S3-S7.
16. Allingham RR, Damji K, Freedman S, et al. Management of the glaucoma patients. In: Shields' Textbook of Glaucoma. 5th ed. Lippincott Williams & Wilkins: Philadelphia, PA, 2005, pp 437-445.
17. Armaly MF, Krueger DE, Maunder L, et al. Biostatistical analysis of collaborative glaucoma study, I: summary report of the risk factors for glaucomatous visual field defects. Arch Ophthalmol. 1980;98(12):2163-2171.
18. Wilson R, Walker AM, Dueker DK, Crick RP. Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis. Arch Ophthalmol. 1982;100(5):737-741.
19. Richler M, Werner EB, Thomas D. Risk factors for progression of visual field defects in medically treated patients with glaucoma. Can J Ophthalmol. 1982;17(6):245-248.
20. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma. 1998; 7(6):372-377.
21. Daugeliene L, Yamamoto T, Kitazawa Y. Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefe's Arch Clin Exp Ophthalmol. 1999;237(2):105-108.
22. Suzuki Y, Shirato S, Adachi M, Hamada C. Risk factors for the progression of treated primary open-angle glaucoma: a multivariate life-table analysis. Graefe's Arch Clin Exp Ophthalmol. 1999; 237(6):463-467.
23. Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma. Ophthalmology. 2000;107(9):1688-1692.
24. Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 2000;130(3):274-279.
25. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131(6):699-708.
26. Tezel G, Siegmund KD, Trinkaus K, et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 2001;119(6):813-818.
27. Araie M, Sekine M, Suzuki Y, Koseki N. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology. 1994;101(3):1440-1444.
28. Drance SM, Douglas GR, Airaksinen PJ, et al. Diffuse visual field loss in chronic open-angle glaucoma Am J Ophthalmol. 1987;104(6):577-580.
29. Araie M, Yamagami J, Suzuki Y. Visual field defects in normaltension glaucoma and high-tension glaucoma. Ophthalmology. 1993;100(12):1808-1814.
30. Caplioli J, Spaeth GL. Comparison of visual field defects in the lowtension glaucoma with those in the high-tension glaucomas. Am J Ophthalmol. 1984;97(6):730-737.
31. Chauhan BC, Drance SM, Douglas GR, Johnson CA. Visual field damage in normal-tension and high-tension glaucoma. Am J Ophthalmol. 1989;108(6):636-642.
32. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115(6):777-784.
33. Parrish RK 2nd, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447-1455.
34. McKean-Cowdin R, Wang Y, Wu J, et al. Impact of visual field loss on health related quality of life in glaucoma. The Los Angeles Latino Eye Study. Ophthalmology. 2007;115(6):941-948.
35. Sumi I, Shirato S, Matsumoto S, Araie M. The Relationships between Visual Disability in Patients with Glaucoma. Ophthalmology. 2003;110(2):332-339.
36. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd ed. 2008. Available from: http://www.eugs.org/eng/EGS_guidelines.asp. Accessed 2010 Feb 28.
37. Japan Glaucoma Society. Guidelines for Glaucoma. Tokyo, Japan: Japan Glaucoma Society; 2002.
38. Anderson DR, Patella VM. Automated static perimetry, 2nd ed. CV Mosby: St. Louis, MO, 1993, pp 121-190.
39. Flammer J. The concept of visual filed indices. Graefes Arch Clin Exp Ophthalmol. 1986;224(5):389-392.
40. Hoddap E, Parrish IRA, Anderson DR. Clinical detection in glaucoma. CV Mosby: St. Louis, MO, 1993, pp 84-126.
41. Viswanathan AC, Fitzke FW, Hitchings RA. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997;81(12):1037-1042.
42. Lewis RA, Hayreh SS, Phelps CD. Optic disc and visual field correlations in primary open-angle and low-tension glaucoma. Am J Ophthalmol. 1983;96(2):148-152.
43. Grave EL, Geijssen C. Comparison of glaucomatous visual field defects in patients with high and low intraocular pressures. In: Grave EL, Heijil A, editors. 5th international visual field symposium, Dr W Junk: Hague, 1983, pp101-105.
44. Anderson DR, Hitchings R. A comparative study of visual field of patients with low-tension glaucoma and those with chronic simple glaucoma. In: Grave EL, Heijil A, editors. 5th international visual field symposium, Dr W Junk: Hague, 1983, pp97-99.
45. Cantor L. Achieving low target pressure with today's glaucoma medications. Surv Ophthalmol. 2003;48:S8-S16.